CME Gr Q2 Adj $2.30 Beats $2.20 Estimate, Sales $1.36B Beat $1.34B Estimate
Portfolio Pulse from Benzinga Newsdesk
CME Group (NASDAQ:CME) reported Q2 earnings of $2.30 per share, beating the analyst consensus estimate of $2.20 by 4.55%. This is a 16.75% increase from the same period last year. The company also reported quarterly sales of $1.36 billion, beating the analyst consensus estimate of $1.34 billion by 1.49%, a 9.94% increase from the same period last year.
July 26, 2023 | 11:06 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
CME Group's Q2 earnings and sales exceeded analyst estimates, indicating a strong financial performance. This could potentially lead to a positive impact on the company's stock price in the short term.
CME Group's Q2 earnings and sales have exceeded analyst estimates, which is typically a positive signal to investors and can lead to an increase in the company's stock price. The significant YoY growth in both earnings and sales further strengthens this outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100